Rhinitis Allergic
Oncology·MeSH: Rhinitis, Allergic, Perennial
Prevalence
20000.0 / 100K
Incidence
2000.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| fexofenadine hcl | Sanofi (SNY) |
Frequently asked questions
How many drugs are in development for Rhinitis Allergic?
BioSniper tracks 1 drug in development for Rhinitis Allergic across 1 company.
How many clinical trials target Rhinitis Allergic?
There are 1 clinical trial targeting Rhinitis Allergic tracked by BioSniper.
What is the prevalence of Rhinitis Allergic?
The estimated prevalence of Rhinitis Allergic is approximately 20000.0 per 100,000 population.
Deep-dive into Rhinitis Allergic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis